EFMC-ISMC 2018 Conference, Ljubljana, Slovenia
BioAscent will be exhibiting at this year’s EFMC Symposium which is being held in Ljubljana in Slovenia on the 2nd – 6th September 2018.
Organised by the Slovenian Pharmaceutical Society (FSD) on behalf of the European Federation of Medicinal Chemistry (EFMC), the symposium aims to attract around 1200 delegates from industry and academia.
The event will cover drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology. EFMC-ISMC 2018 will present the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some new areas including carbohydrate-based vaccines and new chemical modalities. Particular emphasis will be put on first-time disclosures, recent highlights in medicinal chemistry and the impact of artificial intelligence in drug discovery.
The BioAscent team (Phil Jones, CSO; Angus Morrison, Director of Chemistry; and Mike Piper, CCO) will be exhibiting at Stand 23. To find out more information, click here. If you would like to arrange a meeting to discuss chemistry or drug discovery with Phil and Angus, please Contact Us.